Tetsol 800 80% w/w Powder for Oral Solution

Maa: Yhdistynyt kuningaskunta

Kieli: englanti

Lähde: VMD (Veterinary Medicines Directorate)

Aktiivinen ainesosa:

Tetracycline Hydrochloride

Saatavilla:

Novartis Animal Health UK Ltd

ATC-koodi:

QJ01AA07

INN (Kansainvälinen yleisnimi):

Tetracycline Hydrochloride

Lääkemuoto:

Powder for oral solution

Prescription tyyppi:

POM-V - Prescription Only Medicine – Veterinarian

Terapeuttinen ryhmä:

Chickens, Pigs

Terapeuttinen alue:

Antimicrobial

Valtuutuksen tilan:

Expired

Valtuutus päivämäärä:

1995-12-05

Valmisteyhteenveto

Tetsol 800 SPC Novartis Animal Health UK Ltd
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Tetsol 800
80% w/w Powder for Oral Solution.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Tetracycline hydrochloride 80.0% on an acidified carrier to 100.0%.
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Powder for oral solution.
Yellow powder.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Pigs and chickens
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For use against diseases caused by _ Clostridium perfringens_ in
chickens and those
caused by _Actinobacillus (Haemophilus) pleuropneumoniae_ in pigs.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None known.
4.5
SPECIAL PRECAUTIONS FOR USE
I)
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None known.
II)
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMALS
Wear suitable protective clothing, eye/face protection and impervious
gloves before
using the product.
Tetsol 800 SPC Novartis Animal Health UK Ltd
Wash hands and exposed skin after handling the product.
Do not handle this product if you are allergic to tetracyclines.
In case of eye contact, rinse abundantly with water.
If you develop symptoms following exposure, such as skin rash, skin or
eye irritation,
you should seek medical advice and show the doctor this warning.
Swelling of the
face, lips or eyes or difficulty with breathing are more serious
symptoms and require
urgent medical attention.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
No specific restrictions.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
For administration in the drinking water for up to 5 days. Allow birds
and animals
access to medicated water only during treatment.
Medicated water should be prepared daily and any medicated water that
is not
consumed within 24 hou